Trial Profile
Multicenter, Randomized, Double-blind phase ? Study of TJCS Eye Drops group and Restasis Eye Drops group for 12 weeks after treatment, each treatment group comparisons for evaluation of efficacy and safety in moderate to severe dry eye disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms TJCS Study
- Sponsors Taejoon Pharm
- 06 Sep 2016 New trial record